Immediate Impact
1 from Science/Nature 41 standout
Citing Papers
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Artificial intelligence in drug development
2025 Standout
Works of Shenmiao Yang being referenced
Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study
2020
Meis1 is critical to the maintenance of human acute myeloid leukemia cells independent of MLL rearrangements
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Shenmiao Yang | 166 | 88 | 142 | 35 | 279 | |
| Max J. Gordon | 160 | 58 | 194 | 41 | 334 | |
| Laura Fogliatto | 124 | 86 | 68 | 32 | 205 | |
| Amber B. Koehler | 278 | 68 | 213 | 28 | 324 | |
| Márcia Torresan Delamain | 124 | 137 | 68 | 52 | 265 | |
| Ruemu Birhiray | 81 | 69 | 79 | 30 | 233 | |
| Masa Lasica | 149 | 112 | 120 | 44 | 285 | |
| Emma Verner | 119 | 64 | 125 | 35 | 204 | |
| Wanda Knopińska‐Posłuszny | 70 | 104 | 119 | 37 | 321 | |
| Guy Cantin | 77 | 158 | 56 | 23 | 275 | |
| Juan Besalduch | 114 | 147 | 178 | 23 | 332 |
All Works
Login with ORCID to disown or claim papers
Loading papers...